- Home
- QMCO vs ENTA Comparison
QMCO vs ENTA Comparison
Compare QMCO & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- ENTA
- Stock Information
- Founded
- QMCO 1980
- ENTA 1995
- Country
- QMCO United States
- ENTA United States
- Employees
- QMCO N/A
- ENTA N/A
- Industry
- QMCO Electronic Components
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- QMCO Technology
- ENTA Health Care
- Exchange
- QMCO Nasdaq
- ENTA Nasdaq
- Market Cap
- QMCO 157.2M
- ENTA 164.6M
- IPO Year
- QMCO N/A
- ENTA 2013
- Fundamental
- Price
- QMCO $10.29
- ENTA $11.01
- Analyst Decision
- QMCO Hold
- ENTA Strong Buy
- Analyst Count
- QMCO 2
- ENTA 5
- Target Price
- QMCO $19.00
- ENTA $21.00
- AVG Volume (30 Days)
- QMCO 3.1M
- ENTA 1.6M
- Earning Date
- QMCO 11-12-2025
- ENTA 11-24-2025
- Dividend Yield
- QMCO N/A
- ENTA N/A
- EPS Growth
- QMCO N/A
- ENTA N/A
- EPS
- QMCO N/A
- ENTA N/A
- Revenue
- QMCO $266,079,000.00
- ENTA $64,806,000.00
- Revenue This Year
- QMCO N/A
- ENTA $0.07
- Revenue Next Year
- QMCO $5.30
- ENTA N/A
- P/E Ratio
- QMCO N/A
- ENTA N/A
- Revenue Growth
- QMCO N/A
- ENTA N/A
- 52 Week Low
- QMCO $2.88
- ENTA $4.09
- 52 Week High
- QMCO $90.64
- ENTA $15.34
- Technical
- Relative Strength Index (RSI)
- QMCO 48.78
- ENTA 54.52
- Support Level
- QMCO $11.18
- ENTA $10.87
- Resistance Level
- QMCO $13.42
- ENTA $12.02
- Average True Range (ATR)
- QMCO 1.40
- ENTA 1.03
- MACD
- QMCO -0.15
- ENTA -0.03
- Stochastic Oscillator
- QMCO 13.21
- ENTA 20.27
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.